However Lillys demonstration that a GIP/GLP-1 receptor co-agonist (tirzepatide) has superior efficacy compared to selective GLP-1 receptor agonists, has renewed interest in the first incretin. Lilly rolled out their SURPASS trials to position their agent amongst existing diabetes medications and GLP-1 agonists
Semaglutide works by reducing appetite, delaying gastric emptying, increasing insulin release, and lowering the amount of glucagon released
More than 70% believe GLP-1s are accessible only to higher-income Americans, and over half say theyre limited to those with good insurance
Palantir and Tampa General partner on innovation to enhance hospital tech
Because the medicine enters the fatty tissue directly, it bypasses the digestive system and the livers first-pass metabolism
Effects of gastric inhibitory polypeptide on glucose and lipid metabolism of isolated rat adipocytes